InvestorsObserver
×
News Home

Do Analysts Agree on Entasis Therapeutics Holdings Inc (ETTX) Stock's Target Price?

Wednesday, October 28, 2020 12:01 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree on Entasis Therapeutics Holdings Inc (ETTX) Stock's Target Price?

Wall Street is positive on Entasis Therapeutics Holdings Inc (ETTX). On average, analysts give ETTX a Strong Buy rating. The average price target is $6.5, which means analysts expect the stock to climb by 289.22% over the next twelve months.

That average ranking earns ETTX an Analyst Rating of 80, which is better than 80% of stocks based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating ETTX a Strong Buy today. Find out what this means to you and get the rest of the rankings on ETTX!

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.

InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Entasis Therapeutics Holdings Inc Stock Today?

Entasis Therapeutics Holdings Inc (ETTX) stock is trading at $1.67 as of 11:57 AM on Wednesday, Oct 28, a drop of -$0.10, or -5.5% from the previous closing price of $1.77. The stock has traded between $1.65 and $1.76 so far today. Volume today is less active than usual. So far 310,053 shares have traded compared to average volume of 742,147 shares.

Click Here to get the full report on Entasis Therapeutics Holdings Inc (ETTX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App